Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George P Kim

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|April 18, 2014
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsBrian A Costello, Mitesh J Borad, Yingwei Qi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
American Journal of Clinical Oncology|March 23, 2011
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical TrialSteven Robert Alberts, Tom R Fitch, George P Kim, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 22, 2011
Retransplantation for donor-derived neuroendocrine tumorRehana Begum, Denise Harnois, Raj Satyanarayana, et al.
Medical Education|December 11, 2019
A comparison of teaching opportunities for rural and urban family medicine residentsAaron Jattan, Charles G Penner, Marsha Giesbrecht, et al.
The Oncologist|March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic AdenocarcinomaThorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Molecular Oncology|April 13, 2015
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancerYanhong Deng, Li Wang, Shuyun Tan, et al.
Cancer|July 29, 2010
Obesity adversely affects survival in pancreatic cancer patientsRobert R McWilliams, Martha E Matsumoto, Patrick A Burch, et al.
Mayo Clinic Proceedings|May 12, 2007
Treatment options for hepatobiliary and pancreatic cancerSteven R Alberts, Gregory J Gores, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trialsFrank A Sinicrope, Nathan R Foster, Harry H Yoon, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|April 18, 2014
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsBrian A Costello, Mitesh J Borad, Yingwei Qi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
American Journal of Clinical Oncology|March 23, 2011
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical TrialSteven Robert Alberts, Tom R Fitch, George P Kim, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 22, 2011
Retransplantation for donor-derived neuroendocrine tumorRehana Begum, Denise Harnois, Raj Satyanarayana, et al.
Medical Education|December 11, 2019
A comparison of teaching opportunities for rural and urban family medicine residentsAaron Jattan, Charles G Penner, Marsha Giesbrecht, et al.
The Oncologist|March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic AdenocarcinomaThorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Molecular Oncology|April 13, 2015
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancerYanhong Deng, Li Wang, Shuyun Tan, et al.
Cancer|July 29, 2010
Obesity adversely affects survival in pancreatic cancer patientsRobert R McWilliams, Martha E Matsumoto, Patrick A Burch, et al.
Mayo Clinic Proceedings|May 12, 2007
Treatment options for hepatobiliary and pancreatic cancerSteven R Alberts, Gregory J Gores, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trialsFrank A Sinicrope, Nathan R Foster, Harry H Yoon, et al.
Pageof 5